NCT04954560View on ClinicalTrials.gov

Effect of Losartan or Eprosartan on Fructose Hyperuricemia

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 1, 2008

Primary Completion Date

January 1, 2010

Study Completion Date

January 1, 2010

Conditions
Uric Acid Concentration, Serum, Quantitative Trait Locus 7
Interventions
DRUG

losartan and eprosartan

. Each study drug was given in a random order as a single morning dose (50 mg of losartan or 600 mg of eprosartan) for two periods each lasting 3 months separated by 2-week wash-out time.

All Listed Sponsors
lead

Medical University of Lodz

OTHER

NCT04954560 - Effect of Losartan or Eprosartan on Fructose Hyperuricemia | Biotech Hunter | Biotech Hunter